OTC Markets OTCPK - Delayed Quote USD

Bayer Aktiengesellschaft (BAYZF)

20.73

0.00

(0.00%)

At close: January 10 at 3:00:00 PM EST

Agtech seedlings: Bayer, European refinery to scale US biofuel production

Also in this week's farm technology news: Inari raised $144 million to bring gene-edited seeds to market and an Israel-based startup looks to develop its computer vision technology for horticulture.

Agriculture Dive 2 days ago

BAYN.DE
Bayer Secures End of Roundup Weedkiller Litigation in Australia

The German pharmaceutical and agricultural conglomerate said the Federal Court of Australia closed the last pending case in the country over whether its Roundup weedkiller causes cancer.

The Wall Street Journal 9 days ago

BAYRY

BAYZF
0.00%
Bayer: Federal Court Brings an End to Roundup™ Litigation in Australia

LEVERKUSEN, Germany, January 03, 2025--The Federal Court of Australia brought an end to the last Roundup™ case in Australia, closing all pending injury litigation there. The Court granted the plaintiffs’ request to discontinue the Fenton class action against Monsanto involving allegations related to Roundup™. This action follows the company’s earlier victory in the McNickle case in the same court.

Business Wire 9 days ago

BAYRY

BAYZF
0.00%
A year after Bayer got rid of bosses and asked staff to self-organize, its CEO says attrition has fallen

Bayer told workers to self-organize last year as part of a plan to save €2 billion in costs by 2026.

Fortune 19 days ago

BAYN.DE
FDA Accepts Cytokinetics' Application for Cardiovascular Drug

CYTK's NDA is seeking approval for the lead pipeline candidate, aficamten, which the FDA accepted and assigned a target action date of Sept. 26, 2025.

Zacks last month

CYTK

BAYN.DE
FDA Accepts Bayer's Application for Label Expansion of Nubeqa

Bayer's efforts to expand Nubeqa's label in prostate cancer make progress with the FDA's acceptance of the company's sNDA.

Zacks last month

BAYN.DE

PFE
Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan

BAYRY enters into a collaboration and license agreement with Cytokinetics for the exclusive development and commercialization of aficamten in Japan.

Zacks last month

BAYN.DE

CYTK

PFE
Bayer acquires rights to Cytokinetics' heart drug in Japan

Bayer on Tuesday struck a collaboration deal with U.S. biotech firm Cytokinetics to acquire certain rights in Japan to an experimental heart drug, as the German group strengthens its cardiovascular business with smaller deals. Cytokinetics will receive 50 million euros ($53 million) upfront, plus up to 90 million euros contingent on certain development achievements, Bayer said in a statement. Cytokinetics also stands to receive up to 490 million euros from Bayer, depending on certain sales milestones.

Reuters last month

CYTK

BAYN.DE
Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline Setback

AZN and BAYRY announce Q3 results. ABBV's studies on schizophrenia candidate, emraclidine, fail to meet goal.

Zacks last month

AZN

ABBV

BAYN.DE
Agtech seedlings: Bayer gets into the AI business with Microsoft

Also in this week's farm technology news: Nutella maker Ferrero invests in hazelnut research, and digital crop monitoring platform FarmQA acquires competitor Farm Dog.

Agriculture Dive last month

MSFT

BAYN.DE
Bayer Third Quarter 2024 Earnings: Misses Expectations

Bayer ( ETR:BAYN ) Third Quarter 2024 Results Key Financial Results Revenue: €9.97b (down 3.6% from 3Q 2023). Net loss...

Simply Wall St. last month

BAYRY

BAYZF
0.00%
Bayer AG (BAYRY) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

Bayer AG (BAYRY) reports strong performance in Pharmaceuticals and Consumer Health, while facing headwinds in Crop Science and regulatory challenges.

GuruFocus.com last month

BAYN.DE
Bayer urges investor patience as weak agricultural market drags earnings

The chemical giant cut its financial outlook as it faces slowing crop protection sales and regulatory uncertainty around glyphosate and dicamba herbicides.

Agriculture Dive last month

BAYN.DE
Bayer Q3 Earnings Miss Estimates, Nubeqa, Kerendia Boost Sales

BAYRY's third-quarter earnings get affected due to impairment losses at the Crop Science division. Sales gain from the Pharmaceutical business's strong performance.

Zacks last month

BAYN.DE
Stocks to Watch Tuesday: Tesla, Honeywell, Home Depot, Tyson Foods

↗️ Shopify (CA:SHOP, SHOP): The online-retail services company reported better-than-expected quarterly revenue and said growth could be even higher in the key fourth quarter. U.S.-listed shares rocketed about 25%.

The Wall Street Journal last month

TSLA

SHOP

BAYRY
Bayer Stock Slumps on Outlook Cut

Bayer shares are sinking in German trading after the pharmaceuticals and crop science conglomerate reduced its full-year earnings target amid a tough agricultural market.

Investopedia last month

BAYN.DE

ADM
Trending tickers: Coinbase, Tesla, AstraZeneca, Metro Bank and SoftBank

The latest investor updates on stocks that are trending on Tuesday.

Yahoo Finance UK last month

OXINF

IFNNF

IFNNY
Bayer Cuts Earnings Target, Posts Net Loss on Agriculture Weakness

The pharmaceutical-and-agricultural group lowered its profit target for 2024 after tough market conditions hit its crop-science division, sending shares down in early trade.

The Wall Street Journal last month

BAYRY

BAYZF
0.00%
Bayer wins FDA clearance for Medrad Centargo CT injection system

The CT injection system is a multi-patient injector that integrates with other Bayer products and allows for automated injection of contrast media for administering CT scans.

Medical Device Network 2 months ago

BAYN.DE
Stocks to watch next week: Burberry, SSE, Disney, Alibaba and AstraZeneca

Earnings preview of key companies reporting next week and what to look out for.

Yahoo Finance UK 2 months ago

VLXGF

IFMNF

TSN

Performance Overview

Return	BAYZF	DAX P
YTD	+4.96%	+1.54%
1-Year	-46.22%	+21.13%
3-Year	-59.68%	+26.76%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bayer Aktiengesellschaft (BAYZF)

Agtech seedlings: Bayer, European refinery to scale US biofuel production

Bayer Secures End of Roundup Weedkiller Litigation in Australia

Bayer: Federal Court Brings an End to Roundup™ Litigation in Australia

A year after Bayer got rid of bosses and asked staff to self-organize, its CEO says attrition has fallen

FDA Accepts Cytokinetics' Application for Cardiovascular Drug

FDA Accepts Bayer's Application for Label Expansion of Nubeqa

Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan

Bayer acquires rights to Cytokinetics' heart drug in Japan

Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline Setback

Agtech seedlings: Bayer gets into the AI business with Microsoft

Bayer Third Quarter 2024 Earnings: Misses Expectations

Bayer AG (BAYRY) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

Bayer urges investor patience as weak agricultural market drags earnings

Bayer Q3 Earnings Miss Estimates, Nubeqa, Kerendia Boost Sales

Stocks to Watch Tuesday: Tesla, Honeywell, Home Depot, Tyson Foods

Bayer Stock Slumps on Outlook Cut

Trending tickers: Coinbase, Tesla, AstraZeneca, Metro Bank and SoftBank

Bayer Cuts Earnings Target, Posts Net Loss on Agriculture Weakness

Bayer wins FDA clearance for Medrad Centargo CT injection system

Stocks to watch next week: Burberry, SSE, Disney, Alibaba and AstraZeneca

Performance Overview